Transcriptional profiling of triple-negative breast cancer cell lines treated with OTX015

ABSTRACT: In order to determine the impact on transcription of the novel bromodomain inhibitor OTX015, we treated two triple-negative breast cancer cell lines (MDA-MB-231 and MDA-MB-468) treated with the compound at 24 hours.

ORGANISM(S): Homo sapiens

SUBMITTER: Luca Beltrame 

PROVIDER: E-MTAB-3862 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress